NCT03274999View on ClinicalTrials.gov

Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ Use

NATerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

November 9, 2017

Study Completion Date

November 9, 2017

Conditions
Dry Eye Syndromes
Interventions
DEVICE

TrueTear™ Application

Intranasal and extranasal application of TrueTear™ device for approximately 3 minutes at Day 0 and Day 14.

Trial Locations (1)

SW1E 6AU

Ocular Technology Group International, London

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY